Resources by Therapeutic Area
Speaker: Dan Sikkema, PhD, Vice President Biomarker Services, QuanterixModerator: Dr. Jayshan Carpen, Moderator, Nature Research
April 15 - 18, 2018 | Chicago, IL
Visit us at Booth #1152
Sensitivity of assays for detection of low abundance proteins have been improved by orders of magnitude based on unique properties of nanomaterials.
Reports of spontaneous regression and tumour infiltration with T-lymphocytes makes melanoma candidate for immunotherapies.